Amanote Research
Register
Sign In
Budget Impact Analysis of Utilizing Canagliflozin (CANA) for the Treatment of Type 2 Diabetes Mellitus (T2DM) in an United States Health Plan
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.03.1417
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2014
Authors
L. Vo
S. Martin
Publisher
Elsevier BV
Related search
Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Assessment of the Key Drivers of Cost-Effectiveness in the Economic Modelling of Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Budget Impact Analysis of Adding Dapaglifozin to the Therapy of Diabetes Mellitus Type 2 in Bulgaria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Effect of Treatment Intensification Assumptions on Estimates of Cost-Effectiveness in Type 2 Diabetes Mellitus (T2dm)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Budget Optimization Analysis (BOA) of New Intervention Options for Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P235 the Prevalence of Microalbuminuria in Children With Type 2 Diabetes Mellitus (T2DM)
